Pharmaceuticals, Biotechnology and Life Sciences
SAN CARLOS, Calif., Oct. 25, 2021 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel…
EMERYVILLE, Calif., Oct. 25, 2021 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next…
New York, NY, and Tel Aviv, ISRAEL, Oct. 25, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical, Ltd. (“Todos Medical”) (OTCQB:…
Management to host conference call and webcast at 4:30 pm ET on that dayBoca Raton, Florida, Oct. 25, 2021 (GLOBE…
MINNEAPOLIS , Oct. 25, 2021 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics…
Data from Phase 3 PHALCON-HP trial highlighted in oral presentation and recognized with the ACG Governors Award for Excellence in…
Early Clinical Activity and Safety Profile Support Continued Investigation of Repotrectinib in Pediatric Tumors Harboring ALK, ROS1 or NTRK Alterations…
62% vs. 25% overall response rates with navicixizumab plus paclitaxel in biomarker positive vs. biomarker negative patients using the Xerna™ TME…
BUFFALO, N.Y., Oct. 22, 2021 (GLOBE NEWSWIRE) — Athenex (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development,…
PHILADELPHIA, Oct. 22, 2021 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (the “Company”) (Nasdaq: CNTX), a women’s oncology company developing advanced…